1 Drug Eluting Catheter Market Overview 1.1 Product Overview and Scope of Drug Eluting Catheter 1.2 Drug Eluting Catheter Segment by Type 1.2.1 Global Drug Eluting Catheter Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 PTA 1.2.3 PTCA 1.3 Drug Eluting Catheter Segment by Application 1.3.1 Global Drug Eluting Catheter Sales Comparison by Application: (2021-2027) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Global Drug Eluting Catheter Market Size Estimates and Forecasts 1.4.1 Global Drug Eluting Catheter Revenue 2016-2027 1.4.2 Global Drug Eluting Catheter Sales 2016-2027 1.4.3 Drug Eluting Catheter Market Size by Region: 2016 Versus 2021 Versus 2027 2 Drug Eluting Catheter Market Competition by Manufacturers 2.1 Global Drug Eluting Catheter Sales Market Share by Manufacturers (2016-2021) 2.2 Global Drug Eluting Catheter Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Drug Eluting Catheter Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Drug Eluting Catheter Manufacturing Sites, Area Served, Product Type 2.5 Drug Eluting Catheter Market Competitive Situation and Trends 2.5.1 Drug Eluting Catheter Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Drug Eluting Catheter Players Market Share by Revenue 2.5.3 Global Drug Eluting Catheter Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Drug Eluting Catheter Retrospective Market Scenario by Region 3.1 Global Drug Eluting Catheter Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Drug Eluting Catheter Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Drug Eluting Catheter Market Facts & Figures by Country 3.3.1 North America Drug Eluting Catheter Sales by Country 3.3.2 North America Drug Eluting Catheter Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe Drug Eluting Catheter Market Facts & Figures by Country 3.4.1 Europe Drug Eluting Catheter Sales by Country 3.4.2 Europe Drug Eluting Catheter Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Drug Eluting Catheter Market Facts & Figures by Region 3.5.1 Asia Pacific Drug Eluting Catheter Sales by Region 3.5.2 Asia Pacific Drug Eluting Catheter Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Drug Eluting Catheter Market Facts & Figures by Country 3.6.1 Latin America Drug Eluting Catheter Sales by Country 3.6.2 Latin America Drug Eluting Catheter Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Drug Eluting Catheter Market Facts & Figures by Country 3.7.1 Middle East and Africa Drug Eluting Catheter Sales by Country 3.7.2 Middle East and Africa Drug Eluting Catheter Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Drug Eluting Catheter Historic Market Analysis by Type 4.1 Global Drug Eluting Catheter Sales Market Share by Type (2016-2021) 4.2 Global Drug Eluting Catheter Revenue Market Share by Type (2016-2021) 4.3 Global Drug Eluting Catheter Price by Type (2016-2021) 5 Global Drug Eluting Catheter Historic Market Analysis by Application 5.1 Global Drug Eluting Catheter Sales Market Share by Application (2016-2021) 5.2 Global Drug Eluting Catheter Revenue Market Share by Application (2016-2021) 5.3 Global Drug Eluting Catheter Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Boston Scientific Corporation 6.1.1 Boston Scientific Corporation Corporation Information 6.1.2 Boston Scientific Corporation Description and Business Overview 6.1.3 Boston Scientific Corporation Drug Eluting Catheter Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Boston Scientific Corporation Drug Eluting Catheter Product Portfolio 6.1.5 Boston Scientific Corporation Recent Developments/Updates 6.2 Medtronic 6.2.1 Medtronic Corporation Information 6.2.2 Medtronic Description and Business Overview 6.2.3 Medtronic Drug Eluting Catheter Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Medtronic Drug Eluting Catheter Product Portfolio 6.2.5 Medtronic Recent Developments/Updates 6.3 BD 6.3.1 BD Corporation Information 6.3.2 BD Description and Business Overview 6.3.3 BD Drug Eluting Catheter Sales, Revenue and Gross Margin (2016-2021) 6.3.4 BD Drug Eluting Catheter Product Portfolio 6.3.5 BD Recent Developments/Updates 6.4 Aesculap 6.4.1 Aesculap Corporation Information 6.4.2 Aesculap Description and Business Overview 6.4.3 Aesculap Drug Eluting Catheter Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Aesculap Drug Eluting Catheter Product Portfolio 6.4.5 Aesculap Recent Developments/Updates 6.5 Philips 6.5.1 Philips Corporation Information 6.5.2 Philips Description and Business Overview 6.5.3 Philips Drug Eluting Catheter Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Philips Drug Eluting Catheter Product Portfolio 6.5.5 Philips Recent Developments/Updates 6.6 Biotronik 6.6.1 Biotronik Corporation Information 6.6.2 Biotronik Description and Business Overview 6.6.3 Biotronik Drug Eluting Catheter Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Biotronik Drug Eluting Catheter Product Portfolio 6.6.5 Biotronik Recent Developments/Updates 6.7 Aachen Resonance 6.6.1 Aachen Resonance Corporation Information 6.6.2 Aachen Resonance Description and Business Overview 6.6.3 Aachen Resonance Drug Eluting Catheter Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Aachen Resonance Drug Eluting Catheter Product Portfolio 6.7.5 Aachen Resonance Recent Developments/Updates 6.8 iVascular 6.8.1 iVascular Corporation Information 6.8.2 iVascular Description and Business Overview 6.8.3 iVascular Drug Eluting Catheter Sales, Revenue and Gross Margin (2016-2021) 6.8.4 iVascular Drug Eluting Catheter Product Portfolio 6.8.5 iVascular Recent Developments/Updates 6.9 Acrostak 6.9.1 Acrostak Corporation Information 6.9.2 Acrostak Description and Business Overview 6.9.3 Acrostak Drug Eluting Catheter Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Acrostak Drug Eluting Catheter Product Portfolio 6.9.5 Acrostak Recent Developments/Updates 7 Drug Eluting Catheter Manufacturing Cost Analysis 7.1 Drug Eluting Catheter Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Drug Eluting Catheter 7.4 Drug Eluting Catheter Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Drug Eluting Catheter Distributors List 8.3 Drug Eluting Catheter Customers 9 Drug Eluting Catheter Market Dynamics 9.1 Drug Eluting Catheter Industry Trends 9.2 Drug Eluting Catheter Growth Drivers 9.3 Drug Eluting Catheter Market Challenges 9.4 Drug Eluting Catheter Market Restraints 10 Global Market Forecast 10.1 Drug Eluting Catheter Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Drug Eluting Catheter by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Drug Eluting Catheter by Type (2022-2027) 10.2 Drug Eluting Catheter Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Drug Eluting Catheter by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Drug Eluting Catheter by Application (2022-2027) 10.3 Drug Eluting Catheter Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Drug Eluting Catheter by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Drug Eluting Catheter by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Drug Eluting Catheter Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Drug Eluting Catheter Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Drug Eluting Catheter Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Drug Eluting Catheter Covered in This Study Table 5. Global Drug Eluting Catheter Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Drug Eluting Catheter Sales Market Share by Manufacturers (2016-2021) Table 7. Global Drug Eluting Catheter Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Drug Eluting Catheter Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Drug Eluting Catheter Average Price (US$/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Drug Eluting Catheter Manufacturing Sites and Area Served Table 11. Manufacturers Drug Eluting Catheter Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Drug Eluting Catheter by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Eluting Catheter as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Drug Eluting Catheter Sales by Region (2016-2021) & (K Units) Table 16. Global Drug Eluting Catheter Sales Market Share by Region (2016-2021) Table 17. Global Drug Eluting Catheter Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Drug Eluting Catheter Sales by Country (2016-2021) & (K Units) Table 19. North America Drug Eluting Catheter Sales Market Share by Country (2016-2021) Table 20. North America Drug Eluting Catheter Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Drug Eluting Catheter Revenue Market Share by Country (2016-2021) Table 22. Europe Drug Eluting Catheter Sales by Country (2016-2021) & (K Units) Table 23. Europe Drug Eluting Catheter Sales Market Share by Country (2016-2021) Table 24. Europe Drug Eluting Catheter Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Drug Eluting Catheter Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Drug Eluting Catheter Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Drug Eluting Catheter Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Drug Eluting Catheter Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Drug Eluting Catheter Revenue Market Share by Region (2016-2021) Table 30. Latin America Drug Eluting Catheter Sales by Country (2016-2021) & (K Units) Table 31. Latin America Drug Eluting Catheter Sales Market Share by Country (2016-2021) Table 32. Latin America Drug Eluting Catheter Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Drug Eluting Catheter Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Drug Eluting Catheter Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Drug Eluting Catheter Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Drug Eluting Catheter Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Drug Eluting Catheter Revenue Market Share by Country (2016-2021) Table 38. Global Drug Eluting Catheter Sales (K Units) by Type (2016-2021) Table 39. Global Drug Eluting Catheter Sales Market Share by Type (2016-2021) Table 40. Global Drug Eluting Catheter Revenue (Million US$) by Type (2016-2021) Table 41. Global Drug Eluting Catheter Revenue Share by Type (2016-2021) Table 42. Global Drug Eluting Catheter Price (US$/Unit) by Type (2016-2021) Table 43. Global Drug Eluting Catheter Sales (K Units) by Application (2016-2021) Table 44. Global Drug Eluting Catheter Sales Market Share by Application (2016-2021) Table 45. Global Drug Eluting Catheter Revenue (Million US$) by Application (2016-2021) Table 46. Global Drug Eluting Catheter Revenue Share by Application (2016-2021) Table 47. Global Drug Eluting Catheter Price (US$/Unit) by Application (2016-2021) Table 48. Boston Scientific Corporation Corporation Information Table 49. Boston Scientific Corporation Description and Business Overview Table 50. Boston Scientific Corporation Drug Eluting Catheter Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 51. Boston Scientific Corporation Drug Eluting Catheter Product Table 52. Boston Scientific Corporation Recent Developments/Updates Table 53. Medtronic Corporation Information Table 54. Medtronic Description and Business Overview Table 55. Medtronic Drug Eluting Catheter Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 56. Medtronic Drug Eluting Catheter Product Table 57. Medtronic Recent Developments/Updates Table 58. BD Corporation Information Table 59. BD Description and Business Overview Table 60. BD Drug Eluting Catheter Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 61. BD Drug Eluting Catheter Product Table 62. BD Recent Developments/Updates Table 63. Aesculap Corporation Information Table 64. Aesculap Description and Business Overview Table 65. Aesculap Drug Eluting Catheter Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 66. Aesculap Drug Eluting Catheter Product Table 67. Aesculap Recent Developments/Updates Table 68. Philips Corporation Information Table 69. Philips Description and Business Overview Table 70. Philips Drug Eluting Catheter Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 71. Philips Drug Eluting Catheter Product Table 72. Philips Recent Developments/Updates Table 73. Biotronik Corporation Information Table 74. Biotronik Description and Business Overview Table 75. Biotronik Drug Eluting Catheter Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 76. Biotronik Drug Eluting Catheter Product Table 77. Biotronik Recent Developments/Updates Table 78. Aachen Resonance Corporation Information Table 79. Aachen Resonance Description and Business Overview Table 80. Aachen Resonance Drug Eluting Catheter Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 81. Aachen Resonance Drug Eluting Catheter Product Table 82. Aachen Resonance Recent Developments/Updates Table 83. iVascular Corporation Information Table 84. iVascular Description and Business Overview Table 85. iVascular Drug Eluting Catheter Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 86. iVascular Drug Eluting Catheter Product Table 87. iVascular Recent Developments/Updates Table 88. Acrostak Corporation Information Table 89. Acrostak Description and Business Overview Table 90. Acrostak Drug Eluting Catheter Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 91. Acrostak Drug Eluting Catheter Product Table 92. Acrostak Recent Developments/Updates Table 93. Production Base and Market Concentration Rate of Raw Material Table 94. Key Suppliers of Raw Materials Table 95. Drug Eluting Catheter Distributors List Table 96. Drug Eluting Catheter Customers List Table 97. Drug Eluting Catheter Market Trends Table 98. Drug Eluting Catheter Growth Drivers Table 99. Drug Eluting Catheter Market Challenges Table 100. Drug Eluting Catheter Market Restraints Table 101. Global Drug Eluting Catheter Sales Forecast by Type (2022-2027) & (K Units) Table 102. Global Drug Eluting Catheter Sales Market Share Forecast by Type (2022-2027) Table 103. Global Drug Eluting Catheter Revenue Forecast by Type (2022-2027) & (US$ Million) Table 104. Global Drug Eluting Catheter Revenue Market Share Forecast by Type (2022-2027) Table 105. Global Drug Eluting Catheter Sales Forecast by Application (2022-2027) & (K Units) Table 106. Global Drug Eluting Catheter Sales Market Share Forecast by Application (2022-2027) Table 107. Global Drug Eluting Catheter Revenue Forecast by Application (2022-2027) & (US$ Million) Table 108. Global Drug Eluting Catheter Revenue Market Share Forecast by Application (2022-2027) Table 109. Global Drug Eluting Catheter Sales Forecast by Region (2022-2027) & (K Units) Table 110. Global Drug Eluting Catheter Sales Market Share Forecast by Region (2022-2027) Table 111. Global Drug Eluting Catheter Revenue Forecast by Region (2022-2027) & (US$ Million) Table 112. Global Drug Eluting Catheter Revenue Market Share Forecast by Region (2022-2027) Table 113. Research Programs/Design for This Report Table 114. Key Data Information from Secondary Sources Table 115. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Drug Eluting Catheter Figure 2. Global Drug Eluting Catheter Market Share by Type in 2020 & 2027 Figure 3. PTA Product Picture Figure 4. PTCA Product Picture Figure 5. Global Drug Eluting Catheter Market Share by Application in 2020 & 2027 Figure 6. Hospital Figure 7. Clinic Figure 8. Other Figure 9. Global Drug Eluting Catheter Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Drug Eluting Catheter Market Size 2016-2027 (US$ Million) Figure 11. Global Drug Eluting Catheter Sales 2016-2027 (K Units) Figure 12. Global Drug Eluting Catheter Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Drug Eluting Catheter Sales Share by Manufacturers in 2020 Figure 14. Global Drug Eluting Catheter Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Drug Eluting Catheter Players: Market Share by Revenue in 2020 Figure 16. Drug Eluting Catheter Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Drug Eluting Catheter Sales Market Share by Region (2016-2021) Figure 18. Global Drug Eluting Catheter Sales Market Share by Region in 2020 Figure 19. Global Drug Eluting Catheter Revenue Market Share by Region (2016-2021) Figure 20. Global Drug Eluting Catheter Revenue Market Share by Region in 2020 Figure 21. United States Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. China Taiwan Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Mexico Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Brazil Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Argentina Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Turkey Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Saudi Arabia Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. UAE Drug Eluting Catheter Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Sales Market Share of Drug Eluting Catheter by Type (2016-2021) Figure 44. Sales Market Share of Drug Eluting Catheter by Application (2016-2021) Figure 45. Sales Market Share of Drug Eluting Catheter by Application in 2020 Figure 46. Revenue Share of Drug Eluting Catheter by Application (2016-2021) Figure 47. Revenue Share of Drug Eluting Catheter by Application in 2020 Figure 48. Manufacturing Cost Structure of Drug Eluting Catheter Figure 49. Manufacturing Process Analysis of Drug Eluting Catheter Figure 50. Drug Eluting Catheter Industrial Chain Analysis Figure 51. Channels of Distribution Figure 52. Distributors Profiles Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

Boston Scientific Corporation Medtronic BD Aesculap Philips Biotronik Aachen Resonance iVascular Acrostak